International Journal on Science and Technology
E-ISSN: 2229-7677
•
Impact Factor: 9.88
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 17 Issue 1
January-March 2026
Indexing Partners
The Future of Medicine, Unlocked: How mRNA technology is revolutionizing the fight against Cancer and HIV
| Author(s) | Ms. Avika Gupta |
|---|---|
| Country | India |
| Abstract | The development of messenger RNA (mRNA) vaccines was the defining scientific breakthrough of the COVID-19 pandemic, fundamentally changing how we approach disease prevention and treatment. Unlike traditional vaccines that use weakened or inactive viruses, mRNA vaccines harness the power of the body's own cells, turning them into temporary protein factories to trigger a powerful immune response. Their success against COVID-19 not only saved millions of lives but also illuminated the vast potential of this technology in other fields. Scientists are now rapidly exploring whether the same revolutionary principles can be applied to two of humanity’s biggest medical challenges: cancer and HIV. This paper explains the ingenious mechanism of mRNA vaccines, details how they are being adapted to create highly personalized treatments for cancer and bring new hope for an HIV cure, and discusses the benefits, limitations, and incredible future that this technology promises for biotechnology and healthcare. |
| Keywords | mRNA vaccines; cancer immunotherapy; HIV vaccine development; personalized medicine; lipid nanoparticle delivery; neoantigens; broadly neutralizing antibodies; biotechnology innovation |
| Field | Biology > Bio + Chemistry |
| Published In | Volume 17, Issue 1, January-March 2026 |
| Published On | 2026-01-16 |
Share this

CrossRef DOI is assigned to each research paper published in our journal.
IJSAT DOI prefix is
10.71097/IJSAT
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.